Yongsan Chemicals, Inc. Overview
| Field | Detail | Source / Status |
|---|---|---|
| Legal name | Yongsan Chemicals, Inc. (용산화학 주식회사) | GlobalData company abstract; Mitsui Chemicals release (Aug 2000) |
| Former name(s) | Dainong Petrochemical Industry Co., Ltd. | GlobalData company abstract |
| Founding year | — | NPD |
| Incorporation jurisdiction | Republic of Korea | Inferred from domicile, all sources |
| Headquarters | Seoul, South Korea. Historical address in trade records: 10th Floor, Yongsan Building, 92 Galwol-dong, Yongsan-gu, Seoul 140-717 (may be outdated; old lot-number address format) | Panjiva shipment records; GlobalData |
| Principal plant | Ulsan Plant, Petrochemical Complex, 32 Sapyeong-ro, Nam-gu, Ulsan, P.O. Box 68 | Panjiva; ImportGenius |
| Stock exchange / ticker | None. Privately held | Kemira press release, Jan 2019 |
| ISIN / CUSIP | Not applicable (unlisted) | — |
| Fiscal year end | Not disclosed; December year-end is the Korean norm (presumed) | NPD |
| Employees (latest) | NPD | NPD |
| Employees (3-year trend) | NPD | NPD |
| Auditor | NPD (Korean external-audit filings, if any, not located) | NPD |
| Market capitalization | Not applicable (unlisted) | — |
| Website | No official corporate website located via search | NPD |
| Historic shareholders (2000) | Mitsui Chemicals 37%; Tomen Corporation 13%; balance (implied ~50%) Yongsan Group | Mitsui Chemicals release, 10 Aug 2000 (Yongsan Group share inferred) |
| Current shareholders | NPD | NPD |
| Key JV | Kemira Yongsan Chemicals Co., Ltd. (Kemira 35%; Yongsan Chemicals implied 65%) | Kemira press release, 14 Jan 2019 (Yongsan share inferred) |
| Historic JV | Yongsan Mitsui Chemicals, Inc. (50:50 with Mitsui Chemicals, est. 25 Jul 2000) | Mitsui Chemicals release, 10 Aug 2000 |
Yongsan Chemicals, Inc. is a privately held South Korean producer of C4 and acrylic-chain chemical intermediates, operating from an integrated site in the Ulsan petrochemical complex. Its historical anchor is maleic anhydride (MA), produced via n-butane oxidation and sold into unsaturated polyester resin, alkyd resin, plasticizer, paper-sizing, agrochemical and coatings markets, together with downstream derivatives such as fumaric acid, DL-malic acid and tetrahydrophthalic anhydride for food-acidulant and resin uses. A second pillar is water-treatment and papermaking chemistry: acrylamide, the cationic monomer dimethylaminoethyl acrylate methyl chloride quaternary salt (DMAEA-MCQ, "Q9"), and — through a 65:35 joint venture with Finland's Kemira — dry polyacrylamide flocculants and retention aids. The company has a long record of partnering with global majors (Mitsui Chemicals, Tomen, Kemira) to access technology and offtake. It exports to the United States, Southeast Asia and elsewhere, but discloses no financial data publicly.
What the company does
Yongsan Chemicals manufactures maleic anhydride and its derivatives, and a range of acrylic-chain water-treatment monomers. The GlobalData abstract lists the following products and inputs associated with the company: n-butane, butadiene, propylene, acrylonitrile, acrylamide, fumaric acid, DL-malic acid, tetrahydrophthalic anhydride, ethylene, dimethylaminoethyl acrylate (DMAEA), the methyl chloride quaternary salt of DMAEA, and others. Several items on that list (n-butane, butadiene, propylene, ethylene, acrylonitrile) are almost certainly feedstocks rather than products sold — n-butane is the MA feedstock and acrylonitrile is the acrylamide feedstock — so the list should be read as describing the company's raw-material and product chains together. (Source: GlobalData "Yongsan Chemicals Inc – Company Review" abstract.)
Company's own description
No annual report, corporate website or self-published business description was located. The nearest proxy for a company-sourced description is the GlobalData abstract, which characterizes the firm as a chemical company manufacturing maleic anhydride and derivatives whose products serve water-treatment flocculation, plasticizers, paper sizes, modified alkyd resins, food additives, preservatives, acidulants, unsaturated polyester resins, alkyd resins, agricultural chemicals and powder food coatings.
Business model and revenue model
| Dimension | Assessment | Confidence |
|---|---|---|
| Revenue model | Almost entirely product sales (bulk and semi-bulk chemicals). No evidence of service, subscription or licensing revenue | Medium (inferred from product profile) |
| Product vs. service mix | ~100% product (inferred) | Medium |
| JV income | Equity-method or consolidated income from Kemira Yongsan Chemicals (accounting treatment NPD) | Low |
| Pricing basis | Commodity-linked (MA prices track n-butane/benzene and Chinese spot markets); specialty premium on food-grade acids and cationic monomers | Medium (industry structure) |
| Sales channels | Direct to industrial customers; export via traders/distributors (US consignees include chemical distributors and food-ingredient importers) | Medium (customs data) |
Value-chain position
Yongsan Chemicals sits in the intermediate layer of the petrochemical chain. Upstream, it buys n-butane (an LPG fraction) and acrylonitrile from refiners and crackers. Midstream, it converts these into MA, acrylamide and cationic monomers. It then partially integrates downstream into derivatives — fumaric and malic acids (food/resin), tetrahydrophthalic anhydride (resins/curing agents), and, via the Kemira JV, finished dry polyacrylamide polymers. Kemira explicitly highlighted that the JV's polymer production is supported by full backward integration into key raw materials, i.e. Yongsan's monomers (Source: Kemira press release, 20 May 2021).
Customer types and end-markets
| End-market | Products used | Evidence |
|---|---|---|
| Composites / construction (UPR) | Maleic anhydride | Product profile; industry structure |
| Coatings / paints (alkyd resins) | Maleic anhydride, THPA | Vietnam customs entry (2022) records MA flakes imported by a Haiphong paint company for paint raw material |
| Plasticizers | Maleic anhydride | GlobalData |
| Paper and board (sizing, retention, drainage) | MA (for paper sizes), acrylamide, Q9, DPAM via JV | GlobalData; Kemira releases 2019/2021 |
| Municipal & industrial water treatment | Acrylamide, DMAEA-MCQ, DPAM | GlobalData; Kemira releases |
| Food & beverage (acidulants, preservatives, coatings) | Fumaric acid, DL-malic acid | GlobalData; US consignees include food-ingredient importers (Foodtopia, Vivion) |
| Agrochemicals | Maleic anhydride derivatives | GlobalData |
| Water-treatment chemical majors (as customers) | Monomers / intermediates | US bill-of-lading records show shipments to Solenis LLC (Sept–Dec 2024) |
Independent characterization
Yongsan Chemicals is best understood as a mid-sized Korean "partner manufacturer": a company that has repeatedly anchored its growth on alliances with larger foreign chemical groups — Mitsui Chemicals and Tomen in acrylamide (pre-2000), Mitsui again through a 50:50 acrylamide JV (2000), and Kemira in polyacrylamide (2019 onward). This model gives it technology access and assured offtake while limiting its own marketing reach. Its MA business, by contrast, is a merchant commodity operation exposed to Chinese overcapacity and volatile C4 feedstock costs. The company's strategic center of gravity has arguably been migrating from commodity MA toward water-treatment and paper chemistry, where the Kemira JV provides a premium, growing outlet.
Strategy
Stated strategy
No company-authored strategy statement is publicly available. Strategy must be inferred from observable actions.
Inferred strategic themes
-
Partner-led technology access. Each major step into a new product line has been taken with a foreign partner: Mitsui/Tomen equity and acrylamide technology; the YMC bio-acrylamide JV using Mitsui's enzyme catalyst; and the Kemira JV for dry polymers.
-
Forward integration into water and paper chemistry. The Kemira JV moves Yongsan from selling monomers to co-owning finished polymer production, with Kemira providing global marketing reach and offtake security (Kemira, Jan 2019).
-
Export diversification. Sustained US exports — including to water-chemistry major Solenis and to food-ingredient importers — indicate an effort to sell higher-value derivatives beyond the domestic market.
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
No company-announced initiatives in this window were located. Observable activity is limited to continued export flows (shipments to Solenis Sept–Dec 2024; US arrivals through Jan 2026).
ESG and cost programs
None disclosed.
Medium-term targets / guidance
None disclosed.
Products & Services
Specifications below are drawn from public sources where available. Where only general industry specifications are known, this is stated.
C4 / Anhydrides
| Product | Description | Forms / specifications | Target customers | Evidence |
|---|---|---|---|---|
| Maleic anhydride (MA, CAS 108-31-6) | Reactive cyclic anhydride from n-butane oxidation | Molten (bulk/ISO tank) and solid flake or powder in 25 kg bags; purity specs NPD | UPR, alkyd resin, plasticizer, lube-additive, agrochemical, paper-size makers | Panjiva (top product: MA, molten); CIC-TP Vietnam entry |
| Tetrahydrophthalic anhydride (THPA) | Diels-Alder adduct of MA and butadiene | Specs NPD | Alkyd/polyester resins, epoxy curing agents | GlobalData (butadiene listed as input) |
Food & Specialty Acids
| Product | Description | Uses | Evidence |
|---|---|---|---|
| Fumaric acid | Trans-isomer of maleic acid | Food acidulant, UPR/alkyd modifier, paper sizes | GlobalData |
| DL-malic acid | Racemic hydroxysuccinic acid from MA hydration | Beverage/confectionery acidulant, powder food coating | GlobalData; US food-importer consignees (Foodtopia, Vivion) |
Water-Treatment Monomers
| Product | Description | Uses | Evidence |
|---|---|---|---|
| Acrylamide (AAM) | Monomer from acrylonitrile hydration | Feedstock for polyacrylamide flocculants, paper strength resins, EOR polymers | Mitsui release 2000; GlobalData |
| Dimethylaminoethyl acrylate (DMAEA) | Amino-functional acrylate ester | Precursor to cationic monomers | GlobalData |
| DMAEA methyl chloride quaternary salt (DMAEA-MCQ, "Q9", "AMD") | Cationic monomer | Cationic polyacrylamides for sludge dewatering, retention/drainage | GlobalData; Kemira 2019 |
Polymers (Kemira Yongsan Chemicals JV)
| Product | Description | Uses | Launch | Evidence |
|---|---|---|---|---|
| Dry polyacrylamide (DPAM) | High-molecular-weight powder polymers | Retention and drainage in fast paper/board machines; wastewater and sludge dewatering | Plant start-up May 2021 | Kemira releases 2019, 2021 |
| Cationic monomer Q9 (JV output) | As above | Captive feed to DPAM; merchant sales | 2,021 | Kemira 2019 |
Pricing: No list pricing disclosed. One transactional data point: a February 2022 export of 20 tonnes of MA flakes to Vietnam was declared at USD 44,000, implying roughly USD 2,200 per tonne (CIC-TP sample customs data). This is a single shipment, not a price series.
Services: None identified.
Financial Narrative
Disclosure status
No audited or unaudited financial statements for Yongsan Chemicals, Inc. were located in public sources.
Income statement
Revenue CAGR (FY2021–FY2025): not computable (NPD).
Qualitative commentary on likely financial drivers
In the absence of reported figures, the analytically defensible statements concern drivers, not levels:
MA price cycle: Chinese MA prices — the regional price-setter — declined through 2025, starting the year around RMB 6,520/t according to SunSirs' 2025 review, and Chinese spot MA (n-butane route) traded near RMB 5,300–6,000/t in early 2026. In March 2026, prices spiked about 12.5% in a few days (RMB 5,300 to ~5,963/t, 1–4 March) on expectations that a Strait of Hormuz closure would disrupt mixed-butane shipments, with n-butane rising further later that month (SunSirs, 6 and 24 March 2026). For a non-Chinese merchant MA producer, falling 2025 prices likely compressed margins; the 2026 feedstock shock raises both selling prices and costs, with the net effect depending on Yongsan's butane contract structure (NPD).
Kemira JV ramp-up: The DPAM plant started in May 2021, so FY2021–FY2023 likely reflect ramp-up, with steady-state contribution thereafter. Accounting treatment (consolidation vs. equity method) is NPD; at 65% ownership, full consolidation with a 35% non-controlling interest would be the normal K-IFRS outcome if Yongsan holds control.
Capex: The 2019–2021 JV build was the largest identifiable investment; Kemira described its own contribution only as "multi-million." Employee commentary in 2023 referenced ongoing investment in new equipment while criticizing under-investment in existing units (Blind, June 2023; anecdotal).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Analytical Segment Details
| Analytical segment | Contents | Key products | Basis |
|---|---|---|---|
C4 / Anhydrides | n-butane oxidation chain | Maleic anhydride (molten and flake/briquette), tetrahydrophthalic anhydride | GlobalData; Panjiva (molten MA) |
Food & Specialty Acids | MA hydration/isomerization derivatives | Fumaric acid, DL-malic acid | GlobalData |
Water-Treatment Monomers | Acrylic/nitrile chain | Acrylamide, DMAEA, DMAEA-MCQ (Q9) | GlobalData; Kemira |
Polymers (JV) | Kemira Yongsan Chemicals Co., Ltd. | Dry polyacrylamide (DPAM), Q9 | Kemira releases |
Segment revenue (KRW Bn)
| Segment revenue (KRW Bn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Segment operating income (KRW Bn) | FY2023 | FY2024 | FY2025 |
Financial Analysis
| Metric (KRW Bn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Metric (KRW per share) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
Destination Details
| Destination | Evidence | Products | Period |
|---|---|---|---|
United States | 157 shipments (Yongsan Chemicals Inc.) and 227 shipments (Ulsan Plant) in Panjiva; 146 in ImportGenius; ports include Savannah, Houston, Newark, Charleston, Seattle | MA (molten), organic chemicals (HS 29), salts/minerals (HS 25), plastics (HS 39) | 2006 – Jan 2026 |
Vietnam | Customs entry, Haiphong port | MA flakes for paint | Feb 2022 |
Other | ImportKey lists counterparties including Aekyung Chemical, LX MMA, Formosa Chemicals & Fibre, Reliance Industries, Ningxia Hengkang, Gadiv Petrochemical (Israel), Haltermann Carless UK, Petkim (Turkey) — direction of trade (buyer vs. supplier) not clear from the abstract | Mixed | Undated |
Capital Markets
| Metric | FY2021 |
|---|---|
Item | Status |
1/3/5-year share price performance | Not applicable (unlisted) |
Analyst consensus | No coverage |
Dividend policy | NPD |
Credit ratings (Moody's / S&P / Fitch) | None found; Korean domestic ratings (NICE, KIS, KR) not located |
Debt maturity profile | NPD |
Analyst Conclusions
Management guidance and consensus
No management guidance or consensus estimates exist.
Bull case
-
JV-led mix shift. Majority control of the Kemira polymer JV gives Yongsan a growing share of earnings from water-treatment and paper chemistry, a segment with structural APAC growth and less Chinese commoditization than MA (Kemira 2019, 2021).
-
Supply-security premium. Middle East feedstock disruption in 2026 (SunSirs, March 2026) may favor established, reliable non-Chinese suppliers with long customer relationships, as evidenced by a 20-year US export record.
-
Hidden asset value. Long-standing partnerships with Mitsui and Kemira suggest the Ulsan site and technical team are valued by strategic investors, which could support a premium in any future partial sale or partner buy-in.
Bear case
-
MA commoditization. Global MA capacity is projected to outpace demand (Prismane), and Chinese prices fell through 2025 (SunSirs), squeezing margins on Yongsan's top-traded product (Panjiva).
-
Partner dependency. Technology and global distribution sit with partners; Mitsui's 2000 plan to move acrylamide into a separate JV shows how partner strategy can reshape Yongsan's portfolio.
-
Operational and governance opacity. No public financials, plus anecdotal reports of under-investment and low morale (Blind, 2023), make it impossible to verify balance-sheet strength or reinvestment adequacy.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters |
|---|---|
| DART audit report filings (if any) | Would provide the first verifiable financials |
| Kemira annual report disclosures on the Korean JV | Indicates JV performance, capacity expansion or ownership changes |
| Chinese MA and n-butane price trends | Primary driver of MA margins |
| Strait of Hormuz / LPG supply developments | Feedstock cost and availability |
| US tariff policy on Korean chemicals | Affects a key export market |
| Ulsan safety and environmental enforcement | Regulatory and reputational risk |
| Any partner stake changes (Mitsui, Toyota Tsusho, Kemira) | Signals strategic repositioning |
Analyst verdict
Yongsan Chemicals, Inc. is a real, operating, privately held South Korean chemical manufacturer — not a public company, contrary to the input classification. Its identity is well anchored by independent sources: Mitsui Chemicals' 2000 disclosure of its 37% stake and Tomen's 13% stake, Kemira's 2019 and 2021 announcements of a 35%-owned joint venture producing dry polyacrylamide in Ulsan, and a two-decade trail of export shipments to US customers, including Solenis and Huntsman. Beyond that skeleton, the public record is thin. No financial statements, management names, employee counts, capacity figures or strategy documents were found, so a conventional equity-research verdict on valuation or earnings quality cannot responsibly be issued.
What can be said is structural. The company operates two businesses of very different quality. Its maleic anhydride chain is a merchant commodity business facing global capacity growth that exceeds demand growth, with China setting prices and 2026 feedstock volatility adding risk. Its water-treatment and paper chemistry chain — acrylamide, DMAEA, Q9 and the Kemira JV — is structurally more attractive, combining regulatory tailwinds, APAC packaging growth, and a global partner with marketing reach. The JV's backward integration into Yongsan's own monomers is the company's clearest competitive moat.
The central uncertainty is the relative weight of these two businesses in earnings, which is unknowable from public sources. A secondary uncertainty is the current shareholder register: whether Mitsui and Toyota Tsusho (successor to Tomen) remain investors materially affects governance and strategic optionality.
For counterparties evaluating Yongsan as a supplier, partner or acquisition target, the recommended next step is to obtain the Korean external audit report via DART or a commercial credit-bureau profile (NICE, KED), alongside Kemira's segment disclosures.
SOURCES CONSULTED
-
Mitsui Chemicals news release, "Mitsui has New Acrylamide Joint Venture in Korea" — 10 Aug 2000 — Ownership, YMC JV, acrylamide history
-
Mitsui Chemicals, "Introduction of AAM Technology License" — 2022 — 2002 bio-process commercialization at YMC
-
Mitsui Chemicals news release on Polaris Chemicals biocatalysts — 8 Aug 2023 — Acrylamide market context
-
Kemira Oyj press release, "Kemira forms a joint venture in South Korea" — 14 Jan 2019 — JV terms, private ownership status
-
Kemira Oyj press release, "Kemira adds capacity in Asia-Pacific…" — 20 May 2021 — JV plant start-up
-
CHEManager; Process Worldwide; ICIS; Hydrocarbon Engineering — 2019–2021 — Corroboration of JV details
-
GlobalData, "Yongsan Chemicals Inc – Company Review" (abstract) — Undated — Former name, product list, HQ
-
Panjiva; ImportGenius; ImportKey; CIC-TP — 2007–2026 — Addresses, export customers, shipment evidence
-
Blind (teamblind.com) employee reviews — Jun 2023 — Anecdotal labor and operations commentary
-
SunSirs MA market reports — 2025–2026 — MA and n-butane price trends
-
GII Korea abstracts (IMARC, Prismane, Coherent, KBV, Mordor) — 2024–2026 — MA market size and structure
-
MarketScreener; CB Insights — 2024–2026 — Disambiguation from Yongsan Co., Ltd.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Directors' Remuneration
| Role | Name | Tenure | Background | Compensation |
|---|---|---|---|---|
CEO / Representative Director | NPD | NPD | NPD | NPD |
CFO | NPD | NPD | NPD | NPD |
Plant Manager, Ulsan | NPD | NPD | NPD | NPD |
Board of Directors | NPD | NPD | NPD | NPD |
Governance Overview
| Item | Status |
|---|---|
Board independence | NPD; as a private company, no independence requirement under Korean listing rules |
Committee structure | NPD |
Chair/CEO separation | NPD |
Labor relations | A labor union exists at the Ulsan plant; a 2023 employee review discusses union negotiations over the conversion of a 400% regular bonus into ordinary wages (Blind, June 2023; anecdotal) |
Major Shareholders
| Holder | Stake | Date | Source |
|---|---|---|---|
Mitsui Chemicals, Inc. | 37% | As of Aug 2000 | Mitsui Chemicals release |
Tomen Corporation | 13% | As of Aug 2000 | Mitsui Chemicals release |
Yongsan Group (implied) | ~50% | As of Aug 2000 | Inferred residual |
Current ownership | NPD | — | — |
Competitive Landscape
Competitors by Segment
| Product area | Competitor | Country | Positioning vs. Yongsan |
|---|---|---|---|
Maleic anhydride | Huntsman Corporation | US | World's largest MA producer; also a historical customer of Yongsan |
Maleic anhydride | LANXESS | Germany | Major European MA producer |
Maleic anhydride | Polynt Group | Italy | Integrated MA and composite resins |
Maleic anhydride | Mitsubishi Chemical | Japan | Asian MA producer |
Maleic anhydride | Chinese producers (e.g., Shandong-based and Wanhua-linked producers) | China | Large n-butane capacity additions; regional price setters |
Maleic anhydride / food acids | Thirumalai Chemicals; IG Petrochemicals | India | Regional MA and food-acid competitors |
Acrylamide / polyacrylamide | SNF Group | France | Global polyacrylamide leader |
Acrylamide / polyacrylamide | Kemira Oyj | Finland | JV partner; also global competitor in other markets |
Acrylamide / polyacrylamide | BASF | Germany | Polyacrylamide and water-treatment polymers |
Acrylamide | Mitsui Chemicals | Japan | Former partner; enzyme-route acrylamide and biocatalyst licensor |
Fumaric / malic acid | Bartek Ingredients; Fuso Chemical | Canada; Japan | Food-acid specialists |
Peer Comparison FY2024
| Metric | Yongsan Chemicals | Huntsman | Kemira | LANXESS |
|---|---|---|---|---|
Listing | Private | NYSE | Nasdaq Helsinki | Xetra |
Revenue (latest FY) | NPD | ~USD 6.0bn (FY2024, approx.) | ~EUR 2.95bn (FY2024, approx.) | ~EUR 6.4bn (FY2024, approx.) |
Revenue growth | NPD | Verify | Verify | Verify |
Operating margin | NPD | Verify | Verify | Verify |
R&D intensity | NPD | Verify | Verify | Verify |



